BioSpace News Archive

Mind Medicine announced today that members of the Company’s management team will present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference being held on June 27, 2024.

Pierre Fabre Laboratories has been awarded the “Prix Galien International” Prize in the “Best Product for a Rare/Orphan Disease” category for EBVALLO®.

Avantor, Inc. announced that Corey Walker has rejoined the company as President of Avantor’s Laboratory Solutions business, reporting to CEO Michael Stubblefield.

Aprea Therapeutics, Inc. today announced that it will host a virtual KOL event to discuss APR-1051, a highly selective and potentially best-in-class oral WEE1 inhibitor, on Monday, June 24, 2024 at 9:00 AM ET.

Starton Therapeutics Inc. announced today positive interim top-line data from its low-dose lenalidomide STAR-LLD Phase 1b clinical trial in multiple myeloma (MM).

Palatin Technologies, Inc. today announced that it has entered into a warrant inducement agreement with an institutional investor to exercise certain outstanding warrants that the Company issued in November 2022 and October 2023 totaling 3,233,277 shares of the Company’s common stock for gross proceeds of approximately $6.1 million.

Aethlon Medical, Inc. today announced that it will issue financial results for its fiscal year ended March 31, 2024 , at 4:15 p.m. ET on Thursday, June 27, 2024.

Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies

Inozyme Pharma, Inc. announced a data presentation and sponsored symposium at the 11th International Conference on Children’s Bone Health, which is being held June 22-25, 2024, in Salzburg, Austria.

Findings from the SURMOUNT-OSA, a study of tirzepatide in patients with obstructive sleep apnea and obesity, were announced, revealing significant improvements in both sleep apnea severity and related metabolic issues.